Dupixentmyway

One-on-one supplemental injection support training with nurse educators in person, virtually, dupixentmyway by phone.

DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. The mechanism of dupilumab action has not been definitively established. Allergic asthma patients with elevated eosinophils. Patients with coexisting diseases , such as atopic dermatitis or chronic rhinosinusitis with nasal polyposis 1,2. Subjects enrolled in DRI were required to have a history of 1 or more asthma exacerbations that required treatment with systemic corticosteroids or emergency department visit or hospitalization for the treatment of asthma in the year prior to trial entry. Other endpoint: Annualized rate of severe exacerbation events during the week treatment period. Subjects enrolled in QUEST were required to have a history of 1 or more asthma exacerbations that required treatment with systemic corticosteroids or emergency department visit or hospitalization for the treatment of asthma in the year prior to trial entry.

Dupixentmyway

Our commitment to patients extends beyond developing therapies. We understand obtaining access to treatment can be complicated. To help, we have remained committed to developing patient support services and programs that provide assistance, including:. Committed to maintaining this level of service, we continue to closely monitor the health care environment to understand how changes in public policy, the private insurance market, and other areas may affect patients. Our passion is to improve access to medicines and healthcare. Sanofi Patient Connection is an access and support program in the U. Home Your Health Patient Support. Patient Support. Patient Community Charter. For patients in the U. To help, we have remained committed to developing patient support services and programs that provide assistance, including: Helping patients navigate the complexities of their insurance plans both private and public Researching alternative forms of funding and reimbursement Providing free or subsidized treatment for eligible patients with no other options Access to educational resources and programs for patients to learn more about their disease and treatment Assigning individual case managers who work one-on-one with qualified patients in the U. Sanofi Patient Connection.

And for me to teach.

Atopic Dermatitis : for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Asthma : as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Chronic Rhinosinusitis with Nasal Polyposis CRSwNP : as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis. Eosinophilic Esophagitis : for the treatment of adult and pediatric patients aged 12 years, weighing at least 40 kg, and older with eosinophilic esophagitis EoE. Eosinophilic Esophagitis : for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis EoE.

Please ensure that you are filling out the correct form that corresponds to the appropriate indication. First, allow the patient to review the Patient Authorization and Certifications. Then, ensure the patient has signed and dated twice at the top of the form where indicated, as it is vital to the process that the patient reads and agrees to both the Patient Authorization and the Certifications. To help ensure a seamless enrollment process, ask the patient if they would like to provide their email address, mobile phone number, and to consent to receiving text messages. Ensure that the Healthcare Provider has read and agrees to the Healthcare Provider Certification, and signs and dates the prescription at the bottom. A list of potential codes is provided within the Enrollment Form for reference. Be sure to provide only one ICD code, even if the patient has comorbid disease.

Dupixentmyway

One-on-one supplemental injection support training with nurse educators in person, virtually, or by phone. Insightful tips, tools, and resources designed to help you along your journey. DUPIXENT MyWay offers support, answers to your treatment and insurance questions, and a dedicated support team to help you get started and stay on track with your prescribed treatment plan. Or, click this link through your mobile device.

Tatuajes de letras

Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Sanofi US and Regeneron provide these links as a service to its website visitors and users; however, they take no responsibility for the information on any website but their own. When I get the order for the patient, I get really excited. You and your doctor should also discuss the potential benefits and risks of treatment with DUPIXENT including the most common side effects such as injection site reactions, and some serious side effects such as allergic reactions including anaphylaxis, eye problems and inflammation of your blood vessels. US-DAS 1. Submit your request for reimbursement. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. Click Tap to Learn More. Download and fill out the enrollment form with your patients. Refer your appropriate asthma patients to a specialist today Partner with an asthma specialist to help your patients. Let your stomach expand [pause], and now your rib cage, and your chest. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.

Our commitment to patients extends beyond developing therapies.

Find a spot where you can be still and quiet. Once final approval and payment are received, the patient coordinates shipment to their home Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. Allow the breath to come steadily out of your nose until your lungs are completely empty. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed. Be sure to check your inbox. Patient Resources. This can be seated, standing, or laying down. Chronic rhinosinusitis with nasal polyposis: injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, high count of a certain white blood cell eosinophilia , trouble sleeping insomnia , toothache, gastritis, and joint pain arthralgia. Tell your healthcare provider right away if you have: rash, chest pain, worsening shortness of breath, a feeling of pins and needles or numbness of your arms or legs, or persistent fever. Very quaint. Are you sure you want to leave? If the patient is eligible for copay assistance, the patient or caregiver can then ensure the copay assistance is applied, coordinate delivery with the specialty pharmacy, Sanofi Patient Connection Provider Portal.